secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001013762-23-001586
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus appoints George Sekulich to board and Willis Lee as Chairman
-------------------------------------------------------------------

- George Sekulich appointed to fill board vacancy created by Yutaka Niihara's resignation on Sept 25, 2023.
- Sekulich also serves as Co-President and Chief Commercial Officer; previously SVP and CIO since July 2019.
- Willis Lee, Co-President and COO, appointed as Chairman of the Board of Directors on October 2, 2023.
- No family relationships or related-party transactions with Sekulich were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000101376223001586/0001013762-23-001586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000101376223001586/ea186291-8k_emmaus.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-001586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer